LOUISVILLE, Ky. — Research and development of advanced technologies have contributed to the understanding of how the human microbiome impacts health and disease, and the translation of this knowledge into microbiome-based therapeutics and diagnostics.
Dr. Joseph Petrosino, interim chair and professor in the Department of Molecular Virology and Microbiology at Baylor College of Medicine and director of the Alkek Center for Metagenomics and Microbiome Research, will discuss “The Human Microbiome in Precision Medicine: (Way) Beyond Fecal Transplantation,” at 1 p.m. Friday, Oct. 12 in the Kosair Charities Clinical and Translational Research Building, University of Louisville Health Sciences Center campus.
Petrosino will highlight the CMMR’s study of the microbiome and autoimmune disease, neuro-developmental disorders, cancer and Type 1 diabetes. The center’s research efforts include benchmarking and validation of protocols and strategies for metagenomics analyses. Notably, the CMMR has made a significant investment in preclinical model systems to facilitate host-microbe studies and connect the association to causality.
Petrosino’s talk is part of Research!Louisville, now in its 23rd year of showcasing health-related research at the Louisville Medical Center.
“This annual event highlights new knowledge being developed in our city,” said Dr. Chris States, co-chair of Research!Louisville. “The effort results not only in dissemination of research but also presents investigators with the opportunity for future collaboration in the advancement of science.”
Research!Louisville is Oct. 8-12 with exhibits of scientific research, lectures and workshops for professional students, scholars, faculty, postgraduates and others interested in the biomedical research fields. The week-long event is sponsored by the University of Louisville, Norton Healthcare and Jewish Hospital & St. Mary’s Foundation.
The complete schedule of events can be found on the Research!Louisville website: http://researchlouisville.org/2018-event-schedule.